Peptides Dermorphin 5mg CAS：77614-16-5

**Dermorphin** is a natural peptide compound from frog skin that has strong analgesic and analgesic effects. It is a member of the endogenous opioid peptides, specifically, a peptide secreted from frog skin. Its chemical structure is similar to other opioid substances such as morphine, but its analgesic effect is much stronger than morphine.

### Physical and chemical properties:

- **Chemical structure**: Dermorphin is a peptide composed of 7 amino acids, with the chemical name **Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2**. Its structure has two aromatic amino acids (Tyrosine Tyr and Phe Phe), as well as some biologically active amino acids.

- **Molecular weight**: The molecular weight of Dermorphin is approximately **1023 Da**.

- **Solubility**: Due to its peptide properties, Dermorphin is soluble in water, but is more stable at extremely low pH values. Its solubility is similar to other small molecule opioid compounds.

### Biological action:

Dermorphin has a very strong **analgesic effect**, usually about 30 to 40 times stronger than morphine. It exerts its biological action by binding to opioid receptors, especially the μ-receptor (mu-opioid receptor). Due to its very strong affinity for opioid receptors, it can quickly exert a strong analgesic effect and has low tolerance. Compared with other opioid substances, Dermorphin not only has a strong analgesic effect, but also may have fewer side effects, especially at low doses.

### Dosage and use:

The dosage of Dermorphin depends on the use scenario and the way of administration. Its use in drug development is mainly as a strong analgesic, and it is also used to treat acute or chronic pain in some animal experiments. For research or clinical use, the dosage of Dermorphin needs to be adjusted according to individual differences, the degree of pain, and the combined use of other drugs.

Common dosage range:

- **In animal experiments**: Usually administered at the microgram level, the dosage varies depending on the purpose of the experiment, generally 0.01 to 1 microgram per kilogram of body weight.

- **Clinical research**: Dermorphin, as a potential analgesic, has not yet been widely used in clinical practice, but experimental data show that for more severe chronic or acute pain, a lower dose than morphine may be required.

### Half-life and pharmacokinetics:

Dermorphin has a relatively short half-life in the body, usually between a few minutes and more than ten minutes. Its half-life is affected by many factors, including the method of administration, the metabolic rate in the body, and the health status of the user.

Because it is a peptide molecule, Dermorphin usually needs to be injected or other methods (such as transdermal administration) to effectively enter the blood circulation. In the body, it is quickly broken down by enzymes (such as proteases) and loses its biological activity, so continuous administration is required to maintain the analgesic effect.

### Cycle and duration:

Dermorphin has a relatively short duration of action, usually starting to gradually weaken within **30 minutes to several hours** after administration. Compared to other opioid analgesics (such as morphine), Dermorphin's analgesic effect starts very quickly, but its duration of action is short, so frequent dosing may be required.

### Side Effects and Safety:

- **Analgesic effect**: As an opioid peptide, Dermorphin has significant analgesic effects, but due to its strong affinity for μ-receptors, long-term use may lead to some side effects.

- **Addiction**: Although Dermorphin itself is relatively low in addictiveness, as a potent opioid peptide, it also has a certain risk of dependence and tolerance.

- **Respiratory depression**: Like all opioids, Dermorphin may cause respiratory depression in overdose, which is a common and fatal side effect of opioids.

- **Digestive system problems**: Dermorphin may cause digestive side effects such as constipation, which is a common side effect of most opioids.

### Clinical and sports applications:

Currently, Dermorphin is mainly used in the field of **research**, especially in the development of new analgesics. Dermorphin has potential in medicine due to its potent analgesic effect, but it has not been widely used in clinical treatment due to side effects and the risk of abuse.

In sports, Dermorphin has no legal use and is listed as a banned drug, especially in doping tests, where Dermorphin may be considered a banned substance. Its abuse may pose serious health risks, especially due to its potent analgesic effect, which may mask athletes' pain and lead to worsening injuries.

### Summary:

Dermorphin is a potent peptide analgesic derived from frog skin with extremely high μ-opioid receptor affinity and an analgesic effect that is about 30-40 times stronger than morphine. Although it is fast-acting and potent, its use needs to be strictly controlled because excessive use may cause serious side effects such as respiratory depression and addiction. It is currently mainly used in the research field and is being developed as a potential potent analgesic.

### Introduction to Dermorphin

**Dermorphin** is a naturally derived peptide compound extracted from the skin secretions of certain frogs, such as the Mexican **lizard tree frog** (Phyllomedusa sauvagei). It is a mu-opioid receptor agonist with a potent analgesic effect and is more potent than traditional opioids such as morphine, but requires a smaller dose.

### Applicable population

Dermorphin is mainly used for the following populations:

1. **Clinical analgesic patients**: For patients who need strong analgesia but are resistant to traditional opioids, Dermorphin may have certain clinical value as an alternative. It can provide rapid and strong analgesia, but usually requires strict medical supervision.

2. **Chronic pain patients**: For patients with chronic pain, especially those who have long-term use of opioids and have developed tolerance, Dermorphin may provide more effective relief.

3. **Animal models in experimental studies**: Due to its potent biological activity, Dermorphin is often used in animal experiments to study the mechanism of action of opioid receptors and the physiological process of pain.

4. **Other special conditions**: In some cases, such as cancer-induced pain, postoperative analgesia and other fields, Dermorphin may also be used as a candidate drug.

### Working principle

Dermorphin works mainly through its activation of **μ-opioid receptors**. μ-opioid receptors are one of the important receptors in the human body related to pain perception and regulation. By binding to these receptors, Dermorphin can effectively inhibit the transmission of pain signals and produce a strong analgesic effect.

- **Opioid receptor agonism**: Dermorphin is mainly used as an agonist of μ-opioid receptors. Activating these receptors can inhibit the nervous system's response to pain.

- **Analgesic effect**: Because its effect strength exceeds that of traditional opioids, Dermorphin can produce strong analgesic effects at lower doses and reduce side effects.

- **Fast onset**: Its effects occur quickly and last for a short time, which may give it some advantages in the treatment of some acute pain.

### Dosage and Administration

Because Dermorphin is a highly effective and highly bioactive substance, its use and dosage need to be very cautious and is usually used under strict medical supervision. The specific dosage and administration depend on the patient's specific situation and treatment goals. The following are general guidelines:

1. **Dosage**:

- **Adults**: For adult patients, the dose of Dermorphin needs to be adjusted according to their individual pain level, drug tolerance, and response to the drug. Generally, in experimental studies and animal tests, the dosage range is narrow and the dose is small.

- **Start with a low dose**: Given its potent effect, it is usually recommended to start with a lower dose and gradually adjust.

2. **Route of administration**:

- **Injection**: The most common route of administration of Dermorphin is subcutaneous injection or intravenous injection.

- **Other forms of administration**: Not yet popular, but oral or topical use may also occur in experiments.

3. **Precautions**:

- **Side effect monitoring**: When using Dermorphin, you should pay attention to its possible side effects, such as respiratory depression, tolerance, addiction, etc.

- **Gradually increase the dose**: Due to its strong analgesic effect, it may be necessary to gradually increase the dose to ensure the best analgesic effect while minimizing side effects.

- **Dependence and addiction**: Like other opioids, Dermorphin may cause dependence and addiction problems, so strict monitoring and appropriate use cycles are required.

4. **Contraindications**:

- Pregnant and breastfeeding women should avoid using Dermorphin.

- Patients with severe respiratory depression, hepatic and renal insufficiency, or other opioid overuse should avoid using it.

### Summary

Dermorphin is a potent opioid peptide compound with significant analgesic effects. Despite its strong effects, the use of Dermorphin must be carried out under strict medical supervision due to its side effects and addiction potential. For pain management in special circumstances, it may provide an effective treatment option, but it must be used with caution to avoid abuse and improper use.

**Dermorphin** is a natural peptide compound that belongs to a class of endogenous opioid peptides. It is extracted from the skin secretions of certain frogs, such as the *Phyllomedusa* genus in South America. Dermorphin is structurally similar to other opioid peptides, such as endorphins and enkephalins, and therefore has similar physiological effects to opioids, but differs in potency and pharmacological properties.

Here are several possible benefits and applications of Dermorphin:

### 1. **Analgesic effect** Dermorphin, as an opioid peptide, has a potent analgesic effect. Compared with traditional opioids (such as morphine), Dermorphin may have higher potency and lower dosage requirements when providing analgesia. Studies have shown that Dermorphin is dozens of times more potent than morphine, so it may be a potential candidate for the development of new analgesic drugs. Since it is an endogenous peptide, its effects may also have fewer dependence and resistance issues, although this still needs more research to verify.

### 2. **Fewer side effects**

Some studies have shown that Dermorphin may have fewer side effects than traditional opioids. Traditional opioids may cause addiction, respiratory depression, constipation and other problems when used, but due to the different molecular structure and mechanism of action of Dermorphin, it may have a lower risk of these side effects. However, more extensive clinical studies are still needed to confirm its safety.

### 3. **Improved motor function**

Dermorphin has shown an improvement in motor function in some animal experiments. It may affect signal transmission in the nervous system by interacting with opioid receptors, thereby improving motor control. Although this still requires more research and verification, its potential neuroprotective effect may provide a new therapeutic approach for the treatment of motor neuron diseases (such as Parkinson's disease, multiple sclerosis, etc.).

### 4. **Effects on the immune system**

Some studies have pointed out that Dermorphin may have a certain regulatory effect on the immune system. As an opioid peptide, it may affect immune and inflammatory responses, and while this effect has not been fully studied, it provides new directions for possible immunomodulatory treatments.

### 5. **Antidepressant and sedative effects**

Like other opioid peptides, Dermorphin may also have some antidepressant and sedative effects. Studies have shown that certain opioid peptides can improve mood and relieve stress by regulating the balance of neurotransmitters in the brain. As a potent opioid peptide, Dermorphin may help relieve mood disorders such as anxiety and depression by regulating the release of neurotransmitters.

### 6. **Anti-aging effects**

Opioids have been implicated in the regulation of the aging process in some studies. Although there are currently no large studies specifically looking at the anti-aging effects of Dermorphin, its mechanism of action suggests that it may slow the aging process by regulating the nervous system, reducing oxidative stress, and promoting cell repair.

### 7. **Antibacterial effects**

Studies have shown that Dermorphin may have antibacterial properties, especially in its potential to fight certain bacterial infections. Some peptides have natural antimicrobial effects and can disrupt the structure of bacterial cell membranes by interacting with them, thereby preventing bacterial growth. Although research in this area is relatively preliminary, it may provide an interesting idea for the development of new antimicrobial peptides.

### 8. **Influence on mental health and behavior**

Some studies have shown that opioid peptides may affect the role of neurotransmitters (such as dopamine, serotonin, etc.) in the brain, thereby changing people's emotions and behaviors. Dermorphin, as an opioid peptide, may have a certain impact on mental health, especially in relieving anxiety and depression symptoms related to pain.

### 9. **Potential for drug resistance**

Because Dermorphin has a different mechanism of action from other opioids, it may help overcome the problem of existing opioid resistance. The problem of opioid resistance and dependence is a major challenge in current treatment, and Dermorphin may provide a safer and more effective alternative.

### 10. **Neuroprotective effect**

Dermorphin has shown some neuroprotective effects in some animal models and may help slow down the pathological processes associated with neurodegenerative diseases (such as Alzheimer's disease, Parkinson's disease, etc.). The regulatory effects of opioid peptides on the central nervous system may help protect neurons from damage, reduce inflammatory responses and oxidative stress, and thus slow down the progression of neurodegenerative diseases.

### Clinical applications and prospects

Although the research on Dermorphin is still in its early stages, it has shown broad potential in pharmacology and clinical treatment. Future studies may explore how to maximize its therapeutic benefits through different drug delivery methods (such as oral, injection or topical application) and address potential side effects and safety issues. In addition, the use of Dermorphin is still subject to strict legal and ethical restrictions, especially the ethical issues that may arise during its source and extraction process.

In summary,

as a natural opioid peptide, Dermorphin's potential pharmacological effects and therapeutic prospects provide scientists and medical researchers with new directions for exploration. Although our understanding of its benefits and risks is still limited, it is undoubtedly an important research subject in the development of new treatments and drugs in the future.

WhatsApp/Telegram:+852 6749 2648

Gmail:lucasraws207@gmail.com

Skype：live:.cid.8f21dc7fc6621ba7

Hot Tags: peptides dermorphin 5mg cas：77614-16-5, China peptides dermorphin 5mg cas：77614-16-5 manufacturers, suppliers, factory, ACE 031 Add muscle mass and volume, Follistatin 344 Enhance the vitality and growth rate of muscle cells, Follistatin 344 and Fst 344, MGF CAS 12020 86 9, AOD9604 CAS 221231 10 3, Sermorelin CAS 86168 78 7